ELIZA cgi-bash version rev. 1.90
- Medical English LInking keywords finder for the PubMed Zipped Archive (ELIZA) -

return kwic search for study, out of >500 occurrences
300943 occurrences (No.75 in the rank) during 5 years in the PubMed. [no cache] 500 found
225) As a real-world study, the POINT X findings can be generalized to the at-large population.
--- ABSTRACT ---
PMID:24470559 DOI:10.1177/1753193413519926
2015 The Journal of hand surgery, European volume
* Collagenase clostridium histolyticum in patients with Dupuytren's contracture: results from POINT X, an open-label study of clinical and patient-reported outcomes.
- In POINT X, a study designed to reflect clinical practice and patient treatment choices, 254 European patients received open-label collagenase for Dupuytren's contracture. The most severely affected joint was treated first in 74% of patients. In total, 52%, 41%, 7%, and 1% of patients selected the little, ring, middle, and index finger, respectively; 79% had one or two joints treated. Only 9% of patients (n = 24) received 4 or 5 injections. The mean improvement in total passive extension deficit (TPED) was 34° on day 1, improving further by day 7 to 42°. This secondary improvement was maintained by day 90 and month 6. The mean number of injections/joint was 1.2 for the metacarpophalangeal joint and 1.25 for the proximal interphalangeal joint. Median time to recovery was 4 days; the mean improvement in hand function was clinically relevant as measured by the Unité Rhumatologique des Affections de la Main (URAM) score. In total, 87% and 86% of patients and physicians, respectively, were very satisfied or satisfied with treatment at month 6, although correlation between TPED and patient satisfaction was weak (Spearman -0.18, 95% CI -0.32 to -0.06). Collagenase was well tolerated, with 10 (3.9%) patients experiencing severe adverse events. As a real-world study, the POINT X findings can be generalized to the at-large population.
--- ABSTRACT END ---
[
right
kwic]
[frequency of next (right) word to study,]
(1)219 we (6)6 two (11)3 to (16)2 human
(2)85 the (7)4 which (12)2 24 (17)2 in
(3)22 a (8)3 DNA (13)2 an (18)2 serum
(4)11 and (9)3 therefore, (14)2 effects (19)2 six
(5)8 it (10)3 three (15)2 further

add keyword

--- WordNet output for study, --- --- WordNet end ---